These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 10178686)

  • 1. When less is more: cost-containment in transfusion medicine.
    Petrides M
    Transfus Sci; 1997 Dec; 18(4):603-12. PubMed ID: 10178686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening blood for viral genomes: which way to go?
    Allain JP
    Transfus Med; 1998 Mar; 8(1):5-7. PubMed ID: 9569452
    [No Abstract]   [Full Text] [Related]  

  • 3. Scarce resources in an affluent society. Striving for zero risk?
    Gorham M
    Vox Sang; 2002 Aug; 83 Suppl 1():133-6. PubMed ID: 12617122
    [No Abstract]   [Full Text] [Related]  

  • 4. Costing blood products and services.
    Wallace EL
    Transfusion; 1991 May; 31(4):293-5. PubMed ID: 2020991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood transfusion economics in Greece.
    Kyriopoulos JE; Michail-Merianou V; Gitona M
    Transfus Clin Biol; 1995; 2(5):387-94. PubMed ID: 8581182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bottlenecks of blood processing in Uganda.
    Kajja I; Kyeyune D; Bimenya GS; Sibinga CT
    Transfus Med; 2010 Oct; 20(5):329-36. PubMed ID: 20534031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How a blood bank can improve performance.
    Sellers VB
    QRC Advis; 1998 Jun; 14(8):7-12. PubMed ID: 10179838
    [No Abstract]   [Full Text] [Related]  

  • 8. The cost-effective of a small transfusion service laboratory.
    Davis JW; Perone PJ
    MLO Med Lab Obs; 1996 Oct; 28(10):62, 64. PubMed ID: 10161887
    [No Abstract]   [Full Text] [Related]  

  • 9. The cost-effectiveness of pathogen reduction technology as assessed using a multiple risk reduction model.
    Custer B; Agapova M; Martinez RH
    Transfusion; 2010 Nov; 50(11):2461-73. PubMed ID: 20497512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance improvement in a hospital transfusion service.
    Smith DM; Otter J
    Arch Pathol Lab Med; 1999 Jul; 123(7):585-91. PubMed ID: 10388912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current and emerging infectious risks of blood transfusions.
    Busch MP; Kleinman SH; Nemo GJ
    JAMA; 2003 Feb; 289(8):959-62. PubMed ID: 12597733
    [No Abstract]   [Full Text] [Related]  

  • 12. Re-examining blood use to improve quality care.
    Simmons JC
    Qual Lett Healthc Lead; 2001 Sep; 13(9):2-12, 1. PubMed ID: 11570060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfusion medicine in Norway: new problems and new opportunities.
    Flesland O; Seghatchian J
    Transfus Apher Sci; 2006 Oct; 35(2):93-5. PubMed ID: 17030150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Financing blood transfusion services in sub-Saharan Africa: a role for user fees?
    Hensher M; Jefferys E
    Health Policy Plan; 2000 Sep; 15(3):287-95. PubMed ID: 11012403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Leukocyte depletion of blood products: a requirement for improvement of quality and safety].
    De Pauw BE; Van den Bos A
    Ned Tijdschr Geneeskd; 2000 Sep; 144(36):1754-6. PubMed ID: 10992905
    [No Abstract]   [Full Text] [Related]  

  • 16. [Quality assurance in blood transfusion: the advantages and limitations].
    Hergon E
    Transfus Clin Biol; 1998 Apr; 5 Suppl 1():36S-41S. PubMed ID: 9622844
    [No Abstract]   [Full Text] [Related]  

  • 17. A new cost allocation method for hospital-based clinical laboratories and transfusion services: implications for transfusion medicine.
    Liberman A; Rotarius T
    Transfusion; 2005 Oct; 45(10):1684-8. PubMed ID: 16181221
    [No Abstract]   [Full Text] [Related]  

  • 18. The challenge of an increasingly expensive blood system.
    Wilson K; Hébert PC
    CMAJ; 2003 Apr; 168(9):1149-50. PubMed ID: 12719320
    [No Abstract]   [Full Text] [Related]  

  • 19. Improving wastage/utilization of blood and blood components.
    Sellers VB
    QRC Advis; 2000 Nov; 17(1):6-10. PubMed ID: 11188171
    [No Abstract]   [Full Text] [Related]  

  • 20. [Transfusion service of the county of Funen. Organizational and economical aspects of restructuring].
    Georgsen J; Jensen F; Jeppesen S; Rasmussen L; Kristensen T
    Ugeskr Laeger; 1997 Mar; 159(12):1758-62. PubMed ID: 9092156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.